A carregar...

New Medications in the Treatment of Acute Migraine

Migraine is a common disorder affecting 12% of the US population. Use of triptans results in migraine pain relief within 2 hours in 16% to 51% of patients. However, due to their vasoconstrictive properties, triptans are contraindicated in patients with cardiovascular disease, peripheral vascular dis...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Hosp Pharm
Autor principal: Walker, Scot
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6628551/
https://ncbi.nlm.nih.gov/pubmed/31320771
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0018578719844701
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!